Cedars-Sinai Biomanufacturing
Quick Facts: Cedars-Sinai Biomanufacturing
- Signal Score
- 77.3/100 (as of 2026-10-29)
- Quality Compliance
- 92.9/100
- Headquarters
- Los Angeles, CA
- Modalities
- Cell Therapy, Gene Editing
- Active Programs
- 34 confirmed from ClinicalTrials.gov across 19 sponsors
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Cedars-Sinai Biomanufacturing
CDMO.
Signal Score & Pillar Breakdown
Cedars-Sinai Biomanufacturing FDA Inspection History
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2025-03-14 |
Cedars-Sinai Medical Center
West Hollywood, California
Facility-linked
|
Blood and Blood Products | Not posted | No Action Indicated (NAI) |
| 2022-08-26 |
Cedars-Sinai Medical Center
West Hollywood, California
Facility-linked
|
Blood and Blood Products | Yes | Voluntary Action Indicated (VAI) |
Cedars-Sinai Biomanufacturing FDA 483 Findings 7 observations · 2022-08-26 → 2022-08-26 ?
By subsystem
By severity
- 5 — Critical: 2
- 3 — Moderate: 3
- 2 — Minor: 2
- Repeat observations: 0
Most severe findings
-
Required records
"Failure to maintain donor records. Electronic records are used, but they do not meet requirements to ensure that they are trustworthy, reliable and generally equivalent to paper records."
-
Establish, maintain and follow manufacturing SOPs
"Written standard operating procedures including all steps to be followed in the collection of blood and blood components for allogeneic transfusion were not always established. Electronic records are used, but they do not meet requirements to ensure that they are trustworthy, reliable and generally equivalent to paper records."
-
Thorough investigations
"Failure to perform a thorough investigation and make a record of the conclusions and follow-up of an unexplained discrepancy and a failure of a lot or unit to meet any of its specifications."
Clinical Activity 34 studies
Hiring Activity 1 open role Beta
1 mfg/ops 1